Tokyo Tape
Sign in

Tse 2372

2372.TTSE PRIME
Filed as I'rom Group Co., Ltd. (2022-06–2024-11)
Financials · Consolidated
ConsolidatedStandalone
Fiscal year ended2024-032023-032022-032021-032020-032019-03
Revenue¥17.7bn¥18.4bn¥15.7bn¥12.9bn¥10.6bn¥10.6bn
Operating income¥1.1bn¥3.6bn¥2.8bn¥1.1bn——
Ordinary income¥1.8bn¥3.3bn¥2.6bn¥1.4bn¥1.1bn¥1.2bn
Net income (owners)¥1.4bn¥2.5bn¥2.0bn¥1.4bn¥1.2bn¥912m
Total assets¥37.1bn¥35.1bn¥26.6bn¥20.9bn¥15.1bn¥13.5bn
Net assets / equity¥12.8bn¥12.2bn¥10.2bn¥8.7bn¥7.2bn¥6.1bn
Operating cash flow¥446m¥3.6bn¥2.6bn¥374m¥637m¥504m
EPS (basic)¥116.92¥210.22¥162.5¥114.3¥105.82¥78.31

From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 10
AllAnnual 3Half-year 1Quarterly 6202420232022
PeriodFormFiledFigures
2024-04-01 → 2024-09-30Half-year2024-11-0669 figures · EDINET
2023-04-01 → 2024-03-31Annual2024-06-26207 figures · EDINET
2023-04-01 → 2023-12-31Quarterly Q32024-02-0849 figures · EDINET
2023-04-01 → 2023-09-30Quarterly Q22023-11-0773 figures · EDINET
2023-04-01 → 2023-06-30Quarterly Q12023-08-0747 figures · EDINET
2022-04-01 → 2023-03-31Annual2023-06-28209 figures · EDINET
2022-04-01 → 2022-12-31Quarterly Q32023-02-0850 figures · EDINET
2022-04-01 → 2022-09-30Quarterly Q22022-11-0474 figures · EDINET
2022-04-01 → 2022-06-30Quarterly Q12022-08-0548 figures · EDINET
2021-04-01 → 2022-03-31Annual2022-06-28209 figures · EDINET

21 more reports are still being processed.

Segments · FY ended 2024-03
SegmentExternal salesProfitAssets
Advanced Medical¥1.5bn−¥133m¥2.3bn
CRO¥6.4bn¥489m¥5.5bn
Drug Discovery Business—−¥601m—
Medical Support¥1.1bn¥66m¥10.7bn
SMO¥8.7bn¥3.5bn¥7.2bn
Other segments¥25m−¥256m¥1.7bn
Adjustments & eliminations—−¥1.9bn¥9.8bn
Total¥17.7bn¥3.3bn¥25.6bn
Total¥17.7bn¥3.1bn¥27.3bn

Segment names from EDINET member IDs; not mapped to a common taxonomy.